Trial intelligence / Profile preview

Comparison of Dexmedetomidine and Midazolam for Prevention of Emergence Delirium in Children

NCT03337672Completed

Start
Dec 2017
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of dexmedetomidine in emergence delirium (ED) (2 arms). Primary endpoint: Presence of Emergence Delirium (ED) at 20 minutes. Started Dec 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

emergence delirium (ED)

Beyond the preview

Go deeper on NCT03337672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03337672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call